Patient Square Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics.
BiotechHealthtechCambridge, GB
Co-investorsRock Springs CapitalAlbionVCUCL Technology Fund
A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines.
BiotechDeep TechMedical DevicesCambridge, GB
Richard Butt(Chief Scientific Officer)inSanjay Aggarwal(Chief Medical Officer)in
Co-investorsRock Springs CapitalAlbionVC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.